German bacteriologist Paul Ehrlich developed Salvarsan that attacks Treponema pallidum, the sexually transmitted microorganism that causes syphilis in 1909-10 while working at Royal Institute for Experimental Therapy in Frankfurt, Germany. Ehrlich shared the 1908 Nobel Prize in Physiology or Medicine for his work in immunology.
- Synthetic Drugs | CADCA
According to U.S. Customs and Border Protection, many synthetic drugs originate overseas. They were first reported in the U.S. in December 2008, when a shipment of “Spice” was seized and analyzed in Dayton, Ohio.
- Pharmaceutical industry – Wikipedia
Glivec, a drug used in the treatment of several cancers, is marketed by Novartis, one of the world’s major pharmaceutical companies. The pharmaceutical industry discovers, develops, produces, and markets drugs or …. In 1911 arsphenamine, the first synthetic anti-infective drug, was developed by Paul Ehrlich and chemist …
- Drug discovery – Wikipedia
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by … More recently, chemical libraries of synthetic small molecules, natural … exclusivity, marketing and the need to balance secrecy with communication. …. It is very unlikely that a perfect drug candidate will emerge from these early …
- Early drug discovery and the rise of pharmaceutical chemistry.
Until the mid-nineteenth century nature’s pharmaceuticals were all that were available to relieve man’s pain and suffering. The first synthetic drug, chloral hydrate …
- The Pharmaceutical Century – 1800 to 1919 – UAH
Staging the Pharmaceutical Century Quinine and other alkaloids had long been extracted from China bark; but an antifebrile subcomponent, quinoline, was not synthesized in the lab until 1883 by Ludwig Knorr. The first truly synthetic pain reliever, antipyrine, was produced from quinoline derivatives.